Impact of the discovery of membrane inhibitors of complement

Research in Immunology

Volumn 147, Issue 2, 1996, Pages 95-100

  Atkinson, J P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; COMPLEMENT FACTOR H; COMPLEMENT RECEPTOR; DECAY ACCELERATING FACTOR; ENDOGENOUS COMPOUND;

ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 0029942064     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2494(96)87180-X     Document Type: Article

References (58)

1. Deficiency of C3 inactivator in man
2. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21)
3. Separation of self from non-self in the complement system
4. Decay-accelerating factor, a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses
5. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
6. Primary sequence of an alternatively spliced form of CR1: a candidate for the 75,000 Mr complement receptor expressed on chimpanzee erythrocytes
7. The in vivo behavior of complement coated red cells: studies in C6 deficient, C3-depleted and normal rabbits
8. The twenty faces of the fourth component of complement (C4)
9. Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines
10. Complement evasion strategies of microorganisms
11. Primate erythrocyte-immune complex-clearing mechanism
12. The human CD46 molecule is a receptor for measles virus (Edmonton strain)
13. The role of C3 in the immune response
14. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane
15. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte
16. Pathophysiology of immune hemolytic anemia
17. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade
18. Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata
19. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action
20. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
21. Membrane inhibitor of reactive lysis
22. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro
23. Antiphagocytic activity of streptococcal M protein selective binding of complement control factor H
24. The regulators of complement activation (RCA) gene cluster
25. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
26. The interaction of IgE with rat basophilic leukemia cells. I. Evidence for specific binding of IgE
27. Purification of Fcγ receptor from rabbit alveolar macrophages which retains ligand-binding activity
28. The cell surface receptor for IgE. I. The use of repetitive affinity chromatography for the purification of a mammalian receptor
29. Interaction between the third complement component and cell surface macromolecules
30. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster
31. Decay accelerating factor: biochemistry, molecular biology, and function
32. Measles virus and C3 binding sites are distinct on membrane cofactor protein (MCP; CD46)
33. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
34. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity
35. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection
36. Therapeutic regulation of the complement system in acute injury states
37. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
38. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)
39. The alternative pathway of complement activation. The role of C3 and its inactivator (KAF)
40. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical C3 convertase, C4b, 2a
41. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system
42. Identification of complement receptor type one related proteins on primate erythrocytes
43. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi
44. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesion in a model of a cell-cell interaction
45. Membrane cofactor protein (MCP or CD46) is a keratinocyte receptor for the M protein of the group A streptococcus
46. Complement in human reproduction: activation and control
47. Using membrane-bound complement regulatory proteins to inhibit rejection
48. Membrane complement receptors specific for bound fragments of C3
49. Paroxysmal nocturnal hemoglobinuria
50. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1
51. Characterization of ligand-binding activity of isolated murine Fcγ receptor
52. Isolation of a biologically active macrophage receptor for the third component of complement
53. Purification and characterization of a membrane protein (gp45–70) that is a cofactor for cleavage of C3b and C4b
54. The C4 and Slp genes of the complement region of the murine H-2 major histocompatibility complex
55. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF
56. Hypocomplementaemia due to a genetic deficiency of beta 1H globulin
57. Hereditary complement factor I deficiency
58. Decay accelerating factor (CD55) identified as a receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method